Literature DB >> 18596590

Epidemiology of insect-venom anaphylaxis.

Beatrice M Bilò1, Floriano Bonifazi.   

Abstract

PURPOSE OF REVIEW: Knowledge of the epidemiology, natural history and risk factors of insect-venom allergy is crucial for improving the clinical management of allergic patients. This review focuses on the recent research on these aspects of Hymenoptera-sting anaphylactic reactions. RECENT
FINDINGS: The latest data from population-based studies of anaphylactic reactions due to Hymenoptera stings, as well as those extrapolated from studies of epidemiology of anaphylaxis due to any cause are reviewed. The topic of biphasic anaphylactic reactions due to insect stings is also examined. Although no parameter has been identified that can predict which sensitized individuals will have a future anaphylactic reaction, several factors associated with the severity of a systemic resting reaction are known and emphasized here.
SUMMARY: As half of individuals with fatal sting reactions had no documented history of previous systemic reaction, we need to further improve the knowledge of the natural history and risk factors, especially in asymptomatic-sensitized individuals. Moreover, and no less important, the epidemiological studies on sting anaphylaxis conducted in the 2000s continue to reveal the poor management of allergic patients and the startling lack of awareness of the efficacy of venom immunotherapy. These findings indicate the urgent need to educate the general population and doctors on the management of venom-allergic patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18596590     DOI: 10.1097/ACI.0b013e32830638c5

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  40 in total

1.  Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.

Authors:  Susan A Rudders; Aleena Banerji; Daniel P Katzman; Sunday Clark; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2010-07       Impact factor: 6.347

2.  Venom anaphylaxis.

Authors:  Jeffrey Alfonsi; Jason K Lee
Journal:  CMAJ       Date:  2015-06-08       Impact factor: 8.262

3.  Comparability and quality of IgE-based in vitro allergy diagnosis: 25 years of external quality assessment.

Authors:  Lukas Koch; Werner Aberer
Journal:  Wien Klin Wochenschr       Date:  2014-09-06       Impact factor: 1.704

Review 4.  Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.

Authors:  Patrizia Bonadonna; Massimiliano Bonifacio; Carla Lombardo; Roberta Zanotti
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 5.  Hymenoptera Allergy and Mast Cell Activation Syndromes.

Authors:  Patrizia Bonadonna; Massimiliano Bonifacio; Carla Lombardo; Roberta Zanotti
Journal:  Curr Allergy Asthma Rep       Date:  2016-01       Impact factor: 4.806

Review 6.  The pathophysiology of anaphylaxis.

Authors:  Laurent L Reber; Joseph D Hernandez; Stephen J Galli
Journal:  J Allergy Clin Immunol       Date:  2017-08       Impact factor: 10.793

7.  IgE antibodies, FcεRIα, and IgE-mediated local anaphylaxis can limit snake venom toxicity.

Authors:  Philipp Starkl; Thomas Marichal; Nicolas Gaudenzio; Laurent Lionel Reber; Riccardo Sibilano; Mindy Tsai; Stephen Joseph Galli
Journal:  J Allergy Clin Immunol       Date:  2015-09-26       Impact factor: 10.793

Review 8.  IgE and mast cells in host defense against parasites and venoms.

Authors:  Philipp Starkl; Thomas Marichal; Kaori Mukai; Mindy Tsai; Stephen J Galli
Journal:  Semin Immunopathol       Date:  2016-05-25       Impact factor: 9.623

9.  Safety of specific immunotherapy using an ultra-rush induction regimen in bee and wasp allergy.

Authors:  Andrzej Bożek; Krzysztof Kołodziejczyk
Journal:  Hum Vaccin Immunother       Date:  2017-12-06       Impact factor: 3.452

10.  Prevalence and characteristics of Hymenoptera venom allergy in urban school children aged 6 to 18 years living in Trabzon

Authors:  Özge Öziş Baba; Gülay Kaya; Mehtap Haktanır Abul; Neşe Kaklıkkaya; Murat Çakır; Fazıl Orhan
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.